Yildirim H - Search Results

1

Clinical value of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiation of malignant mesothelioma from asbestos-related benign pleural disease: an observational pilot study.

Yildirim H, Metintas M, Entok E, Ak G, Ak I, Dundar E, Erginel S. Yildirim H, et al. J Thorac Oncol. 2009 Dec;4(12):1480-4. doi: 10.1097/JTO.0b013e3181c0a7ff. J Thorac Oncol. 2009. PMID: 19875971

2

Imaging in pleural mesothelioma: a review of imaging research presented at the 9th International Meeting of the International Mesothelioma Interest Group.

Nowak AK, Armato SG 3rd, Ceresoli GL, Yildirim H, Francis RJ. Nowak AK, et al. Among authors: yildirim h. Lung Cancer. 2010 Oct;70(1):1-6. doi: 10.1016/j.lungcan.2010.05.016. Epub 2010 Jun 11. Lung Cancer. 2010. PMID: 20541834 Review.

3

MicroRNA and mRNA features of malignant pleural mesothelioma and benign asbestos-related pleural effusion.

Ak G, Tomaszek SC, Kosari F, Metintas M, Jett JR, Metintas S, Yildirim H, Dundar E, Dong J, Aubry MC, Wigle DA, Thomas CF Jr. Ak G, et al. Among authors: yildirim h. Biomed Res Int. 2015;2015:635748. doi: 10.1155/2015/635748. Epub 2015 Feb 1. Biomed Res Int. 2015. PMID: 25756049 Free PMC article.

4

Soft tissue sarcoma metastatic to pleura.

Yildirim H, Metintaş M, Ak G, Dündar E, Erginel S. Yildirim H, et al. Tuberk Toraks. 2008;56(2):197-200. Tuberk Toraks. 2008. PMID: 18701980

5

Characteristics of lung cancer patients with asbestos-related radiological findings.

Ak G, Metintas M, Metintas S, Erginel S, Alatas F, Yildirim H, Kurt E. Ak G, et al. Among authors: yildirim h. Tuberk Toraks. 2008;56(3):257-65. Tuberk Toraks. 2008. PMID: 18932026

6

Prognostic factors according to the treatment schedule in malignant pleural mesothelioma.

Ak G, Metintas S, Metintas M, Yildirim H, Erginel S, Kurt E, Alatas F, Cadirci O. Ak G, et al. Among authors: yildirim h. J Thorac Oncol. 2009 Nov;4(11):1425-30. doi: 10.1097/JTO.0b013e3181ba2033. J Thorac Oncol. 2009. PMID: 19752758

7

Relationship of metabolic alkalosis, azotemia and morbidity in patients with chronic obstructive pulmonary disease and hypercapnia.

Ucgun I, Oztuna F, Dagli CE, Yildirim H, Bal C. Ucgun I, et al. Among authors: yildirim h. Respiration. 2008;76(3):270-4. doi: 10.1159/000131707. Epub 2008 May 8. Respiration. 2008. PMID: 18463428

8

Predictors of talc pleurodesis outcome in patients with malignant pleural effusions.

Yildirim H, Metintas M, Ak G, Metintas S, Erginel S. Yildirim H, et al. Lung Cancer. 2008 Oct;62(1):139-44. doi: 10.1016/j.lungcan.2008.02.017. Epub 2008 Apr 9. Lung Cancer. 2008. PMID: 18403045 Clinical Trial.

9

Local recurrence of tumor at sites of intervention in malignant pleural mesothelioma.

Metintas M, Ak G, Parspour S, Yildirim H, Erginel S, Alatas F, Batirel HF, Sivrikoz C, Metintas S, Dundar E. Metintas M, et al. Among authors: yildirim h. Lung Cancer. 2008 Aug;61(2):255-61. doi: 10.1016/j.lungcan.2007.12.022. Epub 2008 Mar 4. Lung Cancer. 2008. PMID: 18304688

10

Epidemiology of pleural mesothelioma in a population with non-occupational asbestos exposure.

Metintas M, Metintas S, Ak G, Erginel S, Alatas F, Kurt E, Ucgun I, Yildirim H. Metintas M, et al. Among authors: yildirim h. Respirology. 2008 Jan;13(1):117-21. doi: 10.1111/j.1440-1843.2007.01187.x. Respirology. 2008. PMID: 18197921

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results